Literature DB >> 6382897

Factors influencing beta-cell function and insulin sensitivity in patients with type 2 (non-insulin-dependent) diabetes.

L Groop, E M Tolppanen.   

Abstract

This study was designed to evaluate the influence of age, duration of diabetes, relative body weight and glycaemic control on beta-cell function and insulin sensitivity in 250 patients with onset of nonketotic diabetes between the age of 35 and 70 years (Type 2 diabetes). Beta-cell function was assessed by measuring serum C-peptide concentrations after 1 mg of glucagon iv. It was not influenced by age, age at onset of diabetes nor by the duration of the disease. This suggests that progressive deterioration of beta-cell function with time is not a consistent finding in Type 2 diabetes. Insulin sensitivity, measured as the glucose disappearance rate, KITT, in response to iv-insulin, was not significantly influenced by age or age at onset, but decreased consistently with the duration of the disease (P less than 0.001). Beta-cell function was not correlated to fasting blood glucose and HbA1 concentrations. In contrast, there was a strong inverse relationship between glycaemic control and insulin sensitivity (P less than 0.001) indicating that decreased insulin sensitivity contributes to poor glycaemic control in these patients. Attempts to improve glycaemic control in patients with Type 2 diabetes should therefore include means to improve insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6382897     DOI: 10.1530/acta.0.1060505

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  2 in total

1.  Pancreatic B-cell function in relation to diabetic retinopathy in Asian Indian NIDDM patients.

Authors:  C Snehalatha; R Mohan; V Mohan; A Ramachandran; M Viswanathan
Journal:  Acta Diabetol Lat       Date:  1988 Apr-Jun

2.  Relationship between hypoglycaemic response and plasma concentrations of BTS 67 582 in healthy volunteers.

Authors:  W D Byrom; N E Rotherham; J R Bratty
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.